Business News • PR NewsWire • AbbVie to Present Late-Breaking Results from TURQUOISE-II Study in Chronic Hepatitis C Patients with Cirrhosis at the 2014 International Liver Congress™

AbbVie to Present Late-Breaking Results from TURQUOISE-II Study in Chronic Hepatitis C Patients with Cirrhosis at the 2014 International Liver Congress™

AbbVie to Present Late-Breaking Results from TURQUOISE-II Study in Chronic Hepatitis C Patients with Cirrhosis at the 2014 International Liver Congress™

LONDON, April 12, 2014 /PRNewswire/ -- AbbVie (NYSE:ABBV) announced that new, detailed results from its hepatitis C development program will be presented today at the International Liver CongressTM (ILC) 2014. Data from a pivotal phase III study, TURQUOISE-II, featured in the ILC press...

View More : http://www.prnewswire.com/news-releases/abbvie-to-present-late-breaking-results-from-turquoise-ii-study-in-chronic-hepat...

Releted News by prnewswire

Global Sources launches first Mobile & Wireless show in Asia

New Small Business Ideas For 2014 - Empowered Ezine's Quick Guide To Some Of The Best Opportunities